A study to evaluate the drug Mongersen (GED-0301) for the treatment of Crohn’s disease

Update Il y a 4 ans
Reference: EUCTR2015-001925-18

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

To evaluate the efficacy of GED-0301 compared with placebo on clinical activity at 12 Weeks, in subjects with active Crohn’s disease (CD).


Inclusion criteria

  • Active Crohn's disease